Cost-Effectiveness of Levetiracetam for Patients With Juvenile Myoclonic Epilepsy- A Modeling Approach By The Brazilian Public Health Care System Perspective
Abstract
Authors
M Kayo RP Rosim A Duva AF Ballalai Ferraz E Carmo